Truly INDIVIDUALIZED treatment
for EVERY round of therapy
Our vision is to TRANSFORM LIFE-THREATENING DISEASES INTO TREATABLE CONDITIONS by designing INDIVIDUALIZED therapeutics at EVERY stage of the disease.
The Aummune Therapy
The Need
Today's "personalized medicine" is based on molecular pathways and cancer cells are known to develop resistance to therapies that target a specific pathway.
The Therapy
The Aummune process is based on the company’s breakthrough therapy produced by a proprietary molecular computational process.
The Advantages
Aummune develops a tailored therapy that combats rapidly evolving diseases at every stage.
The Aummune Process
21-Day, De Novo, Personalized Therapy Development
Tumor Sample
Tissue Processing
Evomer™ Computing
Validation
Treatment
Day 0
Day 21
End-to-End Service
Our Team
Guy Neev
CEO
Irit Carmi-Levy, PhD
CSO
Prof. Raanan Berger
CMO
Dr. Ido Bachelet
CTO
Dr. Yaniv Amir
VP R&D
Dr. Yair Schindel
Chairman
Marius Nacht
Co-Founder